Testing effectiveness (Phase 2)WithdrawnNCT02811809
What this trial is testing
Apalutamide Plus Intermittent Hormone Therapy Versus Intermittent Hormone Therapy Alone in Prostate Cancer
Who this might be right for
Prostate Cancer
The University of Texas Health Science Center, Houston